Articles

That means millions more Americans may get access to Lilly’s new GLP-1 pill Foundayo or the GLP-1 injection Zepbound.

This may be the single most important issue facing U.S. democracy today.

The unwinding of the TV bundle was bad for cable companies, but Charter’s reassembling of a bundle of streaming services is helping it dig out and may ultimately be a money saver for consumers.

The department-store chain’s stock is soaring after sales beat expectations — but it’s still trading at a fraction of its record high.

Americans are sharing data from watches, bands and rings with AI platforms, ordering tests through the companies that sell these products, and paying hundreds of dollars in subscription fees.

Washington’s ‘fuzzy math’ impacts inflation and your wallet.

Prediction markets have an insider-trading problem that one-off cases might not solve.

U.S. home-loan rates increased on Thursday but are still lower than a year ago.

“The contributions are invested in mutual funds tracking the S&P 500, small-cap stocks and international equities.”

SpaceX CEO Elon Musk said his firm requested a “short term” deal with Anthropic, despite touting plans that it could last for years.

“I should get some money for my labor. But it feels a little icky to me.”

The stock is surging toward its best day in four years after the discount retailer’s full-year profit outlook was raised.